Jaydutt V Vadgama (Jaydutt Vadgama, Jay Vadgama)

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 29

Top Topics

Breast Cancer Risk

Radical Prostatectomy

Mesenchymal Stem Cells

Vascular Endothelial Growth Factor

Top Venues

Journal of personalized medicine

Journal of clinical medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Qiongyu Hao, Susanne M Henning, Clara E Magyar, Jonathan Said, Jin Zhong, Matthew B Rettig, Jaydutt V Vadgama, Piwen Wang
Enhanced Chemoprevention of Prostate Cancer by Combining Arctigenin with Green Tea and Quercetin in Prostate-Specific Phosphatase and Tensin Homolog Knockout Mice. Biomolecules 14 (1) (2024)
Yanyuan Wu, Marianna Sarkissyan, Ochanya Ogah, Juri Kim, Jaydutt V Vadgama
Correction: Wu et al. Expression of MALAT1 Promotes Trastuzumab Resistance in HER2 Overexpressing Breast Cancers. Cancers 2020, 12 , 1918. Cancers 16 (5) (2024)
Qiongyu Hao, Susanne M Henning, Clara E Magyar, Jonathan Said, Jin Zhong, Matthew B Rettig, Jaydutt V Vadgama, Piwen Wang
Enhanced Chemoprevention of Prostate Cancer by Combining Arctigenin with Green Tea and Quercetin in Prostate-Specific Phosphatase and Tensin Homolog Knockout Mice. Biomolecules 14 (1) (2024)
Qiongyu Hao, Susanne M Henning, Clara E Magyar, Jonathan Said, Jin Zhong, Matthew B Rettig, Jaydutt V Vadgama, Piwen Wang
Enhanced Chemoprevention of Prostate Cancer by Combining Arctigenin with Green Tea and Quercetin in Prostate-Specific Phosphatase and Tensin Homolog Knockout Mice. Biomolecules 14 (1) (2024)
Yanyuan Wu, Eduard Karapetyan, Pranabananda Dutta, Magda Shaheen, Jaydutt V Vadgama
Inflammatory Cytokines Associated with Obesity, Type-2 Diabetes, and Hypertension Exacerbate Breast Cancer Risk in Underserved African American and Latin American Women. Journal of clinical medicine 13 (6) (2024)
Qiongyu Hao, Susanne M Henning, Clara E Magyar, Jonathan Said, Jin Zhong, Matthew B Rettig, Jaydutt V Vadgama, Piwen Wang
Enhanced Chemoprevention of Prostate Cancer by Combining Arctigenin with Green Tea and Quercetin in Prostate-Specific Phosphatase and Tensin Homolog Knockout Mice. Biomolecules 14 (1) (2024)
Yanyuan Wu, Eduard Karapetyan, Pranabananda Dutta, Magda Shaheen, Jaydutt V Vadgama
Inflammatory Cytokines Associated with Obesity, Type-2 Diabetes, and Hypertension Exacerbate Breast Cancer Risk in Underserved African American and Latin American Women. Journal of clinical medicine 13 (6) (2024)
Yanyuan Wu, Marianna Sarkissyan, Ochanya Ogah, Juri Kim, Jaydutt V Vadgama
Correction: Wu et al. Expression of MALAT1 Promotes Trastuzumab Resistance in HER2 Overexpressing Breast Cancers. Cancers 2020, 12 , 1918. Cancers 16 (5) (2024)
Qiongyu Hao, Susanne M Henning, Clara E Magyar, Jonathan Said, Jin Zhong, Matthew B Rettig, Jaydutt V Vadgama, Piwen Wang
Enhanced Chemoprevention of Prostate Cancer by Combining Arctigenin with Green Tea and Quercetin in Prostate-Specific Phosphatase and Tensin Homolog Knockout Mice. Biomolecules 14 (1) (2024)
Yong Wu, Jaydutt V Vadgama
Advancing Cancer Research: Insights and Innovations in Pathogenesis and Targeted Therapies. Journal of personalized medicine 13 (3) (2023)
Pranabananda Dutta, Kimberly Paico, Gabriela Gomez, Yanyuan Wu, Jaydutt V Vadgama
Correction: Dutta et al. Transcriptional Regulation of CCL2 by PARP1 Is a Driver for Invasiveness in Breast Cancer. Cancers 2020, 12 , 1317. Cancers 16 (1) (2023)
Hang Chee Erin Shum, Ke Wu, Jaydutt V Vadgama, Yong Wu
Potential Therapies Targeting the Metabolic Reprogramming of Diabetes-Associated Breast Cancer. Journal of personalized medicine 13 (1) (2023)
Yong Wu, Hang Chee Erin Shum, Ke Wu, Jaydutt V Vadgama
From Interaction to Intervention: How Mesenchymal Stem Cells Affect and Target Triple-Negative Breast Cancer. Biomedicines 11 (4) (2023)
Hang Chee Erin Shum, Ke Wu, Jaydutt V Vadgama, Yong Wu
Potential Therapies Targeting the Metabolic Reprogramming of Diabetes-Associated Breast Cancer. Journal of personalized medicine 13 (1) (2023)
Hang Chee Erin Shum, Ke Wu, Jaydutt V Vadgama, Yong Wu
Potential Therapies Targeting the Metabolic Reprogramming of Diabetes-Associated Breast Cancer. Journal of personalized medicine 13 (1) (2023)
Hang Chee Erin Shum, Ke Wu, Jaydutt V Vadgama, Yong Wu
Potential Therapies Targeting the Metabolic Reprogramming of Diabetes-Associated Breast Cancer. Journal of personalized medicine 13 (1) (2023)
Yong Wu, Hang Chee Erin Shum, Ke Wu, Jaydutt V Vadgama
From Interaction to Intervention: How Mesenchymal Stem Cells Affect and Target Triple-Negative Breast Cancer. Biomedicines 11 (4) (2023)
Pranabananda Dutta, Kimberly Paico, Gabriela Gomez, Yanyuan Wu, Jaydutt V Vadgama
Correction: Dutta et al. Transcriptional Regulation of CCL2 by PARP1 Is a Driver for Invasiveness in Breast Cancer. Cancers 2020, 12 , 1317. Cancers 16 (1) (2023)
Yong Wu, Jaydutt V Vadgama
Advancing Cancer Research: Insights and Innovations in Pathogenesis and Targeted Therapies. Journal of personalized medicine 13 (3) (2023)
Qiongyu Hao, Yanyuan Wu, Jaydutt V Vadgama, Piwen Wang
Phytochemicals in Inhibition of Prostate Cancer: Evidence from Molecular Mechanisms Studies. Biomolecules 12 (9) (2022)
Suhui Yang, Chanel Jackson, Eduard Karapetyan, Pranabananda Dutta, Dulcie Kermah, Yong Wu, Yanyuan Wu, John Schloss, Jaydutt V Vadgama
Roles of Protein Disulfide Isomerase in Breast Cancer. Cancers 14 (3) (2022)
Qiongyu Hao, Yong Wu, Yanyuan Wu, Piwen Wang, Jaydutt V Vadgama
Tumor-Derived Exosomes in Tumor-Induced Immune Suppression. International journal of molecular sciences 23 (3) (2022)
Colin Sterling, Diana Márquez-Garbán, Jaydutt V Vadgama, Richard J Pietras
Squalamines in Blockade of Tumor-Associated Angiogenesis and Cancer Progression. Cancers 14 (20) (2022)
Shiliu Tian, Rui Su, Ke Wu, Xuhan Zhou, Jaydutt V Vadgama, Yong Wu
Diaporine Potentiates the Anticancer Effects of Oxaliplatin and Doxorubicin on Liver Cancer Cells. Journal of personalized medicine 12 (8) (2022)
Yanyuan Wu, Pranabananda Dutta, Sheilah Clayton, Amaya McCloud, Jaydutt V Vadgama
Elevated Baseline Serum PD-L1 Level May Predict Poor Outcomes from Breast Cancer in African-American and Hispanic Women. Journal of clinical medicine 11 (2) (2022)
Pranabananda Dutta, Kimberly Paico, Gabriela Gomez, Yanyuan Wu, Jaydutt V Vadgama
Transcriptional Regulation of CCL2 by PARP1 Is a Driver for Invasiveness in Breast Cancer. Cancers 12 (5) (2020)
Yanyuan Wu, Marianna Sarkissyan, Ochanya Ogah, Juri Kim, Jaydutt V Vadgama
Expression of MALAT1 Promotes Trastuzumab Resistance in HER2 Overexpressing Breast Cancers. Cancers 12 (7) (2020)
Qun Li, Qiongyu Hao, Wei Cao, Jieqing Li, Ke Wu, Yahya Elshimali, Donghui Zhu, Qiao-Hong Chen, Guanglin Chen, Jonathan R Pollack, Jaydutt V Vadgama, Yong Wu
PP2Cδ inhibits p300-mediated p53 acetylation via ATM/BRCA1 pathway to impede DNA damage response in breast cancer. Science advances 5 (10) (2019)
Pranabananda Dutta, Marianna Sarkissyan, Kimberly Paico, Yanyuan Wu, Jaydutt V Vadgama
MCP-1 is overexpressed in triple-negative breast cancers and drives cancer invasiveness and metastasis. Breast cancer research and treatment 170 (3) (2018)